Collegium Pharmaceutical Inc (COLL)

Operating profit margin

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	166,961	33,319	17,628	56,232	-23,748
Revenue	US$ in thousands	459,924	400,720	255,854	281,134	295,792
Operating profit margin		36.30%	8.31%	6.89%	20.00%	-8.03%

December 31, 2023 calculation

Operating profit margin = Operating income ÷ Revenue
= $166,961K ÷ $459,924K
= 36.30%

Collegium Pharmaceutical Inc's operating profit margin has shown fluctuations over the past five years. In 2023, the operating profit margin improved significantly to 29.46%, a substantial increase compared to the previous year. This indicates that the company was able to effectively control its operating expenses and generate more profit from its operations in 2023.

In 2022, the operating profit margin was 7.18%, which was lower compared to the margins in 2021 and 2020. However, there was a positive trend from 2022 to 2023, indicating a potential improvement in the company's operational efficiency.

In 2021 and 2020, Collegium Pharmaceutical Inc's operating profit margin was relatively stable at 8.02% and 18.14% respectively. These margins suggest that the company was able to maintain a reasonable level of profitability from its core operations during these years.

Notably, in 2019, Collegium Pharmaceutical Inc had a negative operating profit margin of -8.00%, indicating that the company's operating expenses exceeded its operating income. This was a concerning performance, but the subsequent years showed a turnaround in profitability.

Overall, the positive trend seen in the operating profit margin of Collegium Pharmaceutical Inc from 2019 to 2023 suggests an improvement in the company's operational efficiency and profitability, which is a positive indicator of its financial health.